FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a composition containing copepods fat, and to using this composition for reducing a visceral fat storage. The composition of copepods fat contains wax esters 20-100 wt %, preferentially wax esters 40-85 wt %. The above wax esters consist of monoesters, preferentially mono- or polyunsaturated C16-C22 fatty acids and preferentially monounsaturated C16-C22 fatty alcohols. What is also presented is a preparation containing the above composition.
EFFECT: invention enables preparing the composition used as a drug for preventing or treating abdominal obesity and diabetes mellitus type 2.
22 cl, 3 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION CONTAINING BIOLOGICAL FAT, MEDICINAL PRODUCTS CONTAINING COMPOSITION CONTAINING BIOLOGICAL FAT, AND USING THEM FOR PREVENTING OR TREATING CARDIOVASCULAR DISEASES | 2010 |
|
RU2563995C2 |
| APPLICATION OF NUTRITIVE COMPOSITIONS FOR DISEASES PREVENTION | 2007 |
|
RU2444912C2 |
| BABY NUTRITIONAL COMPOSITIONS INTENDED FOR PREVENTION OF ADIPOSITY | 2006 |
|
RU2444210C2 |
| APPLICATION OF NUTRIENT COMPOSITIONS WITH PHOSPHOLIPIDS, SPHINGOLIPIDS AND CHOLESTEROL | 2006 |
|
RU2414905C2 |
| FOOD PRODUCT FOR DIABETICS | 2005 |
|
RU2380983C2 |
| NOVEL FATTY ACID ANALOGS FOR TREATMENT OF DIABETES | 1999 |
|
RU2221558C2 |
| USE OF FOOD COMPOSITIONS FOR PREVENTION OF DISEASES | 2007 |
|
RU2446827C2 |
| FAT CONTENT CONTROL | 2003 |
|
RU2346688C2 |
| AGENT FOR INHIBITION OF VISCERAL FAT UPTAKE | 2006 |
|
RU2372920C2 |
| COMPOSITIONS FOR PROPHYLAXIS OR RELIEF OF MULTIPLE RISK FACTOR SYNDROMES | 2001 |
|
RU2291707C2 |
